Michel Therien

USPTO Granted Patents = 37 (Patent Applications = 6)

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 6.2

ph-index = 13

Forward Citations = 1,310(Granted Patents)

Location History:

Montreal, CA (1992)
Lavel, CA (1994)
Dollard Des Ormeaux, CA (1998 - 2002)
Kirkland, CA (2001 - 2011)
Laval, CA (1992 - 2014)
Toronto, CA (2018)

Company Filing History:

21 out of 212

Merck Frosst Canada, Inc.

patents

9 out of 76

Merck Frosst Canada & Co.

patents

4 out of 40

Axys Pharmaceuticals, Inc.

patents

4. 2 out of 20

Debiopharm International, S.a.

patents

5. 2 out of 217

Actelion Pharmaceuticals Ltd

Merck Frosst Canada Inc./merck Frosst Canada & Co.

patent

8. 1 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 1992-2018

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10035813 - Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2018-07-31),

2. 8901105 - Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2014-12-02),

3. 8772336 - Cathepsin cysteine protease inhibitors (2014-07-08),

4. 8318748 - Cathepsin cysteine protease inhibitors (2012-11-27),

5. 7973037 - Cathepsin cysteine protease inhibitors (2011-07-05),

6. 7968720 - Secondary amines as renin inhibitors (2011-06-28),

7. 7799805 - Piperidine carboxylic acid amide derivatives (2010-09-21),

8. 7629467 - Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use (2009-12-08),

9. 7375134 - Cathepsin cysteine protease inhibitors (2008-05-20),

10. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors (2002-12-24),

11. 6486194 - Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases (2002-11-26),

12. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) (2002-11-26),

13. 6486141 - Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) (2002-11-26),

14. 6465509 - Pyrones as inhibitors of cyclooxygenase-2 (2002-10-15),

15. 6329421 - Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 (2001-12-11),

Title: The Innovative Mind of Michel Therien

Introduction: Michel Therien, a talented inventor hailing from Laval, Canada, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Michel Therien's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device aimed at improving patient care and outcomes.

Career Highlights: Throughout his illustrious career, Michel Therien has been recognized for his exceptional problem-solving skills and creativity. His inventions have not only pushed the boundaries of technology but have also made a significant impact on various industries.

Collaborations: Michel Therien has collaborated with leading tech companies and research institutions to further develop his inventions and bring them to the market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Michel Therien stands as a visionary inventor whose passion for innovation continues to drive him towards creating solutions that shape the future of technology. His dedication to excellence and relentless pursuit of knowledge make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.